Suresh R. Babu
Head of Chemistry, Manufacturing, and Controls
Dr. Suresh Babu joined BELLUS Health in January 2022 as Vice President, Head of CMC.
Dr. Babu has over 30 years of experience in small biotech to large multinational pharmaceutical companies with technical capabilities in preformulation, bio-enhancement technologies, first in human-dosage development, registration/validation campaigns, and life-cycle product development in oral and parenteral dosage forms. Extensive experience with out-sourcing development and manufacturing of small molecules from preclinical to late-stage to launch readiness.
At BELLUS Health, Dr. Babu leads the Process Chemistry, Formulations, Analytical and Clinical Supply Chain groups. He served as the Vice President of CMC at Forma Therapeutics, Synta Pharmaceuticals and at various leadership/scientific titles at Pfizer Global R&D, Warner-Lambert/Parke-Davis and Johnson and Johnson Pharmaceutical Science organizations.
Dr. Babu is an Emeritus member of the Advisory Board for the School of Pharmacy, University of Connecticut, CT.
BELLUS Health has a strong leadership team that is open to listening and has implemented a nurturing work environment by allowing employees to have a voice as well as rewarding efforts and good performance.